Patents by Inventor Lionel Breton

Lionel Breton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cosmetic/pharmaceutical compositions comprising &bgr;-adrenergic agonists/substance P antagonists
    Patent number: 6267972
    Abstract: Cosmetic/pharmaceutical compositions, well suited for the treatment of a variety of mammalian disorders of, for example, the skin, hair and/or mucous membranes, a manifestation of which is an excess in the synthesis and/or in the release of substance P, e.g., for the treatment of cutaneous disorders and sensitive skin, comprise an effective substance P antagonist amount of at least one &bgr;-adrenergic agonist, e.g., salbutamol, in a cosmetically/pharmaceutically acceptable medium therefor.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: July 31, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Olivier De Lacharriere, Jacques Leclaire
  • Use of cinnamic acid or of its derivatives in a cosmetic firming composition
    Patent number: 6267971
    Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as a firming agent for the skin and/or mucous membranes. The invention also relates to a firming composition comprising cinnamic acid or at least one of its derivatives.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: July 31, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Florence Girerd, Béatrice Renault
  • Use of cinnamic acid or of at least one of its derivatives in a cosmetic composition
    Patent number: 6264962
    Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as an agent for promoting the synthesis of the skin's total lipids. The invention also relates to a cosmetic composition comprising an effective amount of cinnamic acid or of at least one of its derivatives.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: July 24, 2001
    Assignee: Societe l'Oreal S.A.
    Inventors: Lionel Breton, Florence Girerd, Béatrice Renault
  • Therapeutic/cosmetic compositions comprising bradykinin antagonists for treating sensitive human skin
    Patent number: 6241993
    Abstract: Topically applicable pharmaceutical/dermatological/cosmetic compositions well suited for the therapeutic treatment or care of sensitive human skin, hair, mucous membranes, nails and/or the scalp, in particular for reducing or avoiding the skin-irritant side effects of a variety of bioactive agents, for example the &agr;-hydroxy and &bgr;-hydroxy acids, comprise a therapeutically/cosmetically effective amount of at least one bradykinin antagonist.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: June 5, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Olivier De Lacharriere
  • Cosmetic/pharmaceutical compositions comprising microorganism culture media
    Patent number: 6242229
    Abstract: Cosmetic/pharmaceutical compositions, suitable for cosmetic applications and/or for treating a wide variety of mammalian disorders or disease states, comprise an effective active principle amount of a clarified and stabilized culture medium for at least one non-photosynthetic filamentous bacterium, advantageously belonging to the genera Beggiatoa, Vitreoscilla, Flexithrix or Leucothrix, formulated into a cosmetically/pharmaceutically acceptable vehicle, diluent or carrier therefor.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: June 5, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Nathalie Pineau, Richard Martin, Lionel Breton, Lucien Aubert
  • Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
    Patent number: 6235291
    Abstract: The invention concerns the use of a substance P antagonist in a cosmetic composition used to treat sensitive skin. More specifically, the invention relates to a substance P antagonist used to prevent and/or combat skin irritations, desquamation, erythemas, sensations of dysesthesia/overheating, or pruritus of the skin.
    Type: Grant
    Filed: March 11, 1996
    Date of Patent: May 22, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De La Charriere, Lionel Breton
  • Antiwrinkle cosmetic/pharmaceutical compositions comprising iridaceae extracts
    Patent number: 6224850
    Abstract: Cosmetic/pharmaceutical compositions, well suited for the treatment of unwanted skin wrinkles, e.g., for visibly reducing human skin wrinkles, comprise an effective antiwrinkle amount of at least one extract of at least one member of the Iridaceae family that relaxes and/or loosens cutaneous and/or subcutaneous tissue, formulated into a cosmetically/pharmaceutically acceptable excipient or carrier therefor.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: May 1, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Oliver De Lacharriere, Richard Martin
  • Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
    Patent number: 6203803
    Abstract: The invention concerns the use of a substance P antagonist in a cosmetic composition used to treat sensitive skin. More specifically, the invention relates to a substance P antagonist used to prevent and/or combat skin irritations, desquamation, erythemas, sensations of dysesthesia/overheating, or pruritus of the skin.
    Type: Grant
    Filed: June 24, 1997
    Date of Patent: March 20, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De La Charriere, Lionel Breton
  • Alkaline-earth metal salt for the treatment of ocular or palpebral pruritus and dysesthesia
    Patent number: 6168809
    Abstract: The invention relates to the use of an alkaline-earth metal salt in or for the preparation of a cosmetic or pharmaceutical composition, especially for topical application, for treating ocular or palpebral pruritus and/or ocular or palpebral dysesthesia. The cosmetic composition can be used for applying make-up to or removing make-up from sensitive eyes.
    Type: Grant
    Filed: April 10, 1996
    Date of Patent: January 2, 2001
    Assignee: Societe l'Oreal S.A.
    Inventors: Olivier De Lacharriere, Lionel Breton
  • Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids
    Patent number: 6169069
    Abstract: Ocular and/or palpebral pruritus and/or ocular and/or palpebral pain and/or ocular and/or palpebral dysaesthesia afflicting a mammalian, notably human patient, are therapeutically treated by administering to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist; the subject compositions are also well suited for making up and/or caring for human eyes, eyelashes and/or eyelids, especially sensitive eyes and eyelids.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: January 2, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De Lacharriere, Lionel Breton
  • N-aryl-2-hydroxyalkylamido compositions for inducing/stimulating hair growth and/or retarding hair loss and/or for treating hyperseborrhea and/or acne
    Patent number: 6156899
    Abstract: Novel N-aryl-2-hydroxyalkylamido compounds having the formula (I): ##STR1## are well suited for inducing/stimulating hair growth and/or retarding hair loss and/or for therapeutically treating hyperseborrhea and/or acne.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: December 5, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Jean-Baptiste Galey, Odile Destree, Lionel Breton
  • Polyholoside compositions for stimulating the immune system
    Patent number: 6153601
    Abstract: Cosmetic/pharmaceutical/dermatological compositions suited for stimulating the immune system/defenses of a mammalian organism, via topically applying same to the skin of such organism, comprise an immune system-stimulating amount of at least one polyholoside which comprises at least one fucose structural unit, preferably a heterogeneous polyholoside, in a topically applicable, cosmetically/pharmaceutically/dermatologically acceptable vehicle, carrier or diluent therefor.
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: November 28, 2000
    Assignee: Societe l'oreal S.A.
    Inventors: Lionel Breton, Nathalie Pineau, Pierre Desolle
  • Substance P antagonists comprising rosaceae plant extracts
    Patent number: 6146636
    Abstract: Disease states, disorders, conditions or afflictions manifesting excessive synthesis and/or release of substance P are therapeutically treating by administering to individuals in need of such treatment, an effective substance P antagonist amount of at least one extract of at least one plant of the Rosaceae family.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: November 14, 2000
    Assignee: Societe l'Oreal S.A.
    Inventors: Lionel Breton, Nathalie Pineau
  • Skin toning by stimulating collagen synthesis/proliferation of dermal fibroblasts
    Patent number: 6147121
    Abstract: The hydroxystilbenes are effective collagen-synthesizing, and/or fibroblast-proliferating, and/or protease expression-inhibiting, and/or skin aging-combating, and/or flaccid/wrinkled skin-treating, and/or skin-smoothing/firming, and/or menopausal cutaneous effect-treating, and/or menopausal collagen/fibroblast effects-treating active agents, for topical application onto the skin and/or mucous membranes of a human subject in need of such treatment(s).
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: November 14, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Christel Liviero, Dominique Fagot
  • Desquamation/epidermal renewal of the skin and/or combating skin aging
    Patent number: 6124364
    Abstract: The hydroxystilbenes are well suited for promoting desquamation and/or stimulating epidermal renewal and/or combating intrinsic/extrinsic aging of the skin of a human subject in need of such treatment, by topically applying thereto, for such period of time as required to elicit the desired response, a therapeutically effective amount of at least one of said hydroxystilbenes.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: September 26, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Nathalie Pineau
  • Use of at least one thermal spring water from Vichy as a substance P antagonist
    Patent number: 6106846
    Abstract: The present invention relates to the use of at least one thermal spring water from the Vichy basin as substance P antagonist in a cosmetic composition or for the preparation of a pharmaceutical composition. The invention also relates to the use of at least one thermal spring water from the Vichy basin in a cosmetic composition or for the preparation of a pharmaceutical composition, more especially a dermatological composition, intended for treating disorders associated with excessive synthesis and/or release of substance P.
    Type: Grant
    Filed: September 19, 1996
    Date of Patent: August 22, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Jacques Leclaire, Olivier de Lacharriere
  • Method for preventing or treating disorders involving an inflammatory process
    Patent number: 6060061
    Abstract: The subject of the present invention is an extract of at least one plant of the Labiatae family, the said plant being cultured in vitro.Its subject is also a cosmetic or pharmaceutical composition comprising, as active ingredient, at least an effective quantity of the said extract. The invention finally relates to the use of such an extract in a cosmetic composition or for the preparation of a pharmaceutical composition for controlling disorders involving an inflammatory process or an allergic process, and a process of cosmetic treatment involving such an extract.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: May 9, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Richard Martin, Nathalie Pineau
  • Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals
    Patent number: 6057351
    Abstract: Novel compounds of the aryl 2,4 dioxo oxazolidine family, a method for synthesizing same, compositions containing said compounds, and the use of an effective amount of at least one of said compounds as an active principle in a physiologically acceptable medium in a cosmetic composition or for preparing a pharmaceutical composition, are disclosed. Said compound or said compositions are useful for inducing and/or stimulating hair growth and/or controlling hair loss and/or treating hyperseborrhea and/or acne.
    Type: Grant
    Filed: April 5, 1999
    Date of Patent: May 2, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Jean-Baptiste Galey, Lionel Breton, Odile Destree
  • Promoting epidermal renewal with phloroglucinol
    Patent number: 6054137
    Abstract: The subject-matter of the invention is a cosmetic composition comprising, in a cosmetically acceptable medium, at least phloroglucinol or one of its derivatives. Another subject-matter of the invention is the use of phloroglucinol or of its derivatives in a cosmetic composition intended to promote epidermal renewal.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: April 25, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Florence Girerd, Beatrice Renault
  • Topical composition containing capsazepine
    Patent number: 6048855
    Abstract: A topical composition containing capsazepine and particularly suitable for treating neurogenic skin disorders and diseases, especially painful and/or pruriginous diseases, as well as for treating sensitive skin and eyes. In particular, the composition is useful for preventing and/or controlling skin and/or eye irritation, itching, erythema and dysaesthesia and heating of the skin, eyes and mucosa, as well as for reducing the irritancy of an active substance having an irritant side-effect.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: April 11, 2000
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De Lacharriere, Lionel Breton